GDS Wealth Boosts Procter & Gamble Stake 20.9%; Analysts Lift PTs to $170
GDS Wealth Management increased its Procter & Gamble stake by 20.9% to 81,190 shares in Q3, raising its position to $12.48 million. Meanwhile, four analysts raised their price targets—UBS to $170, JPMorgan to $165—driving the consensus Moderate Buy target to $166.70.
1. Procter & Gamble Trades at Multi-Year Lows with Stable Fundamentals
Shares of Procter & Gamble have retreated to levels not seen in over two years, reflecting broad market concerns about consumer spending and margin pressures. Investors have largely discounted worst-case scenarios, pricing in tepid top-line growth. Yet even modest revenue increases are sufficient to sustain P&G’s cash flow and support its long track record of dividend payments, reinforcing the case for compounding value over time.
2. Institutional Investors Adjust Positions in Third Quarter Filings
GDS Wealth Management boosted its Procter & Gamble stake by 20.9% during Q3, acquiring 14,060 additional shares to bring its total to 81,190 shares valued at $12.48 million. BAM Wealth added a new position worth approximately $678,000, while Acorn Wealth Advisors grew its holding by 4.5% to 4,028 shares ($619,000). PFG Investments increased its stake by 1.6% to 54,237 shares ($8.33 million), Symphony Financial lifted its position by 1.9% to 13,771 shares ($2.12 million) and Inlet Private Wealth added 172 shares, taking its total to 11,265 shares ($1.73 million). Collectively, hedge funds and other institutional investors own 65.77% of the company’s outstanding shares.
3. Analysts Lift Ratings and Price Targets on Consumer Staples Strength
Several research firms have turned more positive on P&G’s outlook. JPMorgan Chase upgraded the stock from Neutral to Overweight, raising its target from $157 to $165. UBS increased its Buy target to $170, up from $161. Wells Fargo reiterated an Overweight rating and lifted its objective from $158 to $165. Piper Sandler initiated coverage with a Neutral rating and a $150 target, while Raymond James trimmed its target from $185 to $175 but maintained an Outperform stance. The consensus among 22 analysts is a Moderate Buy, with an average target of $166.70.
4. Q3 Results and Dividend Policy Underscore Financial Discipline
In the fiscal Q3 ended January 22, P&G reported adjusted EPS of $1.88, beating consensus estimates by $0.02, on revenue of $22.21 billion (versus $22.36 billion expected), a 1.5% year-over-year increase. Return on equity stood at 32.1% with a net margin of 19.3%. Management set full-year 2026 EPS guidance at a range of $6.83 to $7.09. The board declared a quarterly dividend of $1.0568 per share ($4.23 annualized), representing a 2.8% yield and a payout ratio of 62.67%, to be paid on February 17 to shareholders of record as of January 23.